← All Biolase, INC filings

Biolase, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

OTC.Pink
BIOLQ
Biolase, INC
S-1: BIOLASE Eyes $24 Million in New Offering to Bolster Working Capital
BIOLASE, Inc. announces a best efforts offering of units and pre-funded units to raise capital for working capital and general corporate purposes.
OTC.Pink
BIOLQ
Biolase, INC
S-1/A: BIOLASE Files for Resale of 4.4 Million Shares Issuable Upon Warrant Exercise
BIOLASE, Inc. has filed a registration statement for the resale of up to 4,443,760 shares of its common stock, which are issuable upon the exercise of outstanding warrants held by a selling stockholder.
OTC.Pink
BIOLQ
Biolase, INC
S-1/A: BIOLASE Announces Offering of Units and Warrants to Bolster Financial Position
BIOLASE, Inc. plans to offer units and warrants in a best-efforts offering to raise capital for working capital and general corporate purposes.
OTC.Pink
BIOLQ
Biolase, INC
S-1/A: BIOLASE Eyes $7.5 Million Capital Injection Through Unit and Warrant Offering
BIOLASE aims to raise capital by offering units and pre-funded units, each including common stock or warrants and Class A and Class B warrants.
OTC.Pink
BIOLQ
Biolase, INC
S-1/A: BIOLASE, Inc. Announces Offering of Up To $7.48 Million in Units and Pre-Funded Units
BIOLASE, Inc., a leading provider of advanced laser systems for the dental industry, is offering up to $7.48 million in units and pre-funded units in a best efforts offering.
OTC.Pink
BIOLQ
Biolase, INC
S-1: BIOLASE Files for Unit Offering to Bolster Working Capital
BIOLASE, Inc. announces a proposed best efforts offering of units and pre-funded units to raise capital for working capital and general corporate purposes.